News
-
-
-
COMMUNIQUÉ DE PRESSE
Anbio introduces cutting-edge “Point of Care” technology in Europe
Anbio Biotechnology expands into the EU market with the AF-100 C immunoassay analyzer, offering over 70 assays to enhance patient care. The cutting-edge analyzer revolutionizes point-of-care testing, delivering rapid and accurate results for healthcare providers